Record Q2 results featured 37% adjusted EBITDA growth, margin expansion, and a record $4.4B backlog. Full-year guidance was raised across all key metrics, with both AA&S and HPMC segments contributing to durable growth. Major capacity investments and strong end-market demand support a positive multi-year outlook.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.